|
|
Name: |
Soleus Capital Management L.P. |
City: |
GREENWICH |
State: |
CT |
Zip: |
06830 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
GSK |
GlaxoSmithKline Plc (ADR) |
3 |
- |
$40.41 |
$47,383,000 |
1,278,540 |
5.26% |
13,199,000 |
335,540 |
0.063 |
Drug Manufacturers - ... |
|
RYZB |
Rayzebio, Inc. |
4 |
- |
$62.49 |
$46,417,000 |
746,622 |
5.15% |
36,401,000 |
295,459 |
1.228 |
N/A |
|
EDAP |
EDAP TMS S.A. (ADR) |
5 |
- |
$6.89 |
$38,155,000 |
7,226,341 |
4.23% |
-5,768,000 |
969,557 |
24.799 |
Medical Appliances & ... |
|
HUM |
Humana Inc |
7 |
- |
$344.50 |
$33,743,000 |
73,706 |
3.74% |
269,000 |
4,904 |
0.056 |
Health Care Plans |
|
CELC |
Celcuity Inc. |
8 |
- |
$16.89 |
$31,755,000 |
2,179,481 |
3.52% |
12,959,000 |
122,997 |
10.058 |
N/A |
|
IRMD |
Iradimed Corp |
9 |
- |
$0.00 |
$30,533,000 |
643,206 |
3.39% |
2,659,000 |
15,000 |
5.242 |
N/A |
|
EPIX |
ESSA Pharma Inc |
10 |
- |
$0.00 |
$28,562,000 |
4,327,622 |
3.17% |
15,315,000 |
40,528 |
9.84 |
Diagnostic Substances |
|
NUVL |
Nuvalent, Inc. |
15 |
- |
$0.00 |
$23,761,000 |
322,888 |
2.64% |
16,662,000 |
168,472 |
0.567 |
N/A |
|
MREO |
Mereo Biopharma Group plc |
16 |
- |
$2.96 |
$22,586,000 |
9,777,419 |
2.51% |
10,102,000 |
100,000 |
9.032 |
N/A |
|
ATRC |
Atricure, Inc. |
20 |
- |
$21.89 |
$13,997,000 |
392,195 |
1.55% |
594,000 |
86,195 |
0.854 |
Medical Instruments &... |
|
VSTM |
Verastem, Inc. |
25 |
- |
$13.16 |
$11,605,000 |
1,425,634 |
1.29% |
651,000 |
78,265 |
5.651 |
Biotechnology |
|
SNDX |
Syndax Pharmaceuticals Inc |
26 |
- |
$21.66 |
$11,108,000 |
514,000 |
1.23% |
9,373,000 |
394,500 |
0.67 |
N/A |
|
TMDX |
Transmedics Group, Inc. |
30 |
- |
$132.44 |
$9,717,000 |
123,112 |
1.08% |
9,717,000 |
123,112 |
0.386 |
N/A |
|
VKTX |
Viking Therapeutics, Inc. |
36 |
- |
$72.50 |
$8,118,000 |
436,200 |
0.9% |
6,765,000 |
314,000 |
0.598 |
N/A |
|
JSPR |
Jasper Therapeutics Ord Shs |
37 |
- |
$15.12 |
$7,788,000 |
9,870,980 |
0.86% |
1,977,000 |
1,570,000 |
9.717 |
N/A |
|
THTX |
Theratechnologies Ord Shs |
38 |
- |
$0.00 |
$7,778,000 |
4,801,376 |
0.86% |
2,766,000 |
2,470,000 |
19.832 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
49 |
- |
$14.67 |
$3,006,000 |
138,000 |
0.33% |
3,006,000 |
138,000 |
0.304 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
51 |
- |
$0.00 |
$2,671,000 |
58,000 |
0.3% |
895,000 |
6,000 |
0.093 |
N/A |
|
PTGX |
Protagonist Therapeutics, Inc |
55 |
- |
$29.61 |
$1,903,000 |
83,000 |
0.21% |
1,903,000 |
83,000 |
0.148 |
N/A |
|
ILMN |
Illumina Inc |
64 |
- |
$115.58 |
$738,000 |
5,300 |
0.08% |
738,000 |
5,300 |
0.004 |
Scientific & Technica... |
|
ADVM |
Adverum Biotechnologies, Inc |
70 |
- |
$8.93 |
$320,000 |
425,000 |
0.04% |
320,000 |
425,000 |
0.098 |
N/A |
|